QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=37B596B4B55CD3647D0279084925B569;jsessionid=447DC72F2F1C3DA9A78FBFD88360156A;jsessionid=68E3435241F1CA02CACBD6BDAEB6AC6F;jsessionid=16BE2AD53FFBC867A172452ADFB07576 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=37B596B4B55CD3647D0279084925B569;jsessionid=447DC72F2F1C3DA9A78FBFD88360156A;jsessionid=68E3435241F1CA02CACBD6BDAEB6AC6F;jsessionid=16BE2AD53FFBC867A172452ADFB07576